Blackwell PublishingDid you know... FEBS Journal has no page charges, and colour is free if Editors judge it to be necessary
FEBS Journal requires authors to use online submission of manuscripts at http://mc.manuscriptcentral.com/febsj/
Step-by-step instructions on how to submit your manuscript online are available during the submission process. Queries can be sent to the Editorial Office (febsj@camfebs.co.uk) and further information can be obtained online from the submission site via the Get Help Now button.
During the submission process the following should be provided:
NB Once you have viewed your pdf proof, you will receive an onscreen acknowledgement of submission with a reference number.
Submission of a revised manuscript
Submit the revised manuscript online to http://mc.manuscriptcentral.com/febsj/ following the instructions provided in the editorial decision letter. You will need to:
NB An acceptance date will not be allocated until the Editorial Office has received a completed Exclusive Licence Form.
Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a lecture, review or thesis), that it is not under consideration for publication elsewhere, that its publication in the present form has been approved by all authors and by the responsible authorities in the institutions where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in any language, without the consent of FEBS, the licence holder. Previously published abstracts, etc should be referred to in the Introduction.
An electronic copy of any related paper under consideration or in press elsewhere should also be submitted to facilitate evaluation by the referees.
Submission of a research article is taken to imply that the authors are willing to make available to academic researchers cell lines, DNA clones, antibodies or similar materials, that have been used in the experiments reported.
Evaluation of manuscripts
Submitted manuscripts are assigned to an Editor of the Journal who is responsible for its evaluation. The Editor's decision regarding publication is based on the reports of referees, which will, at the Editor's discretion, be transmitted to the authors. Authors will be informed of the Editorial decision, on average, within 4-5 weeks of submission of a Regular Paper. The status of each manuscript within the editorial process can be followed online at http://mc.manuscriptcentral.com/febsj/. Enquiries should be addressed to the Editorial Office, email: febsj@camfebs.co.uk.
Authorship
Papers should conform to recommendations for authorship provided by the International Committee of Medical Journal Editors (the Vancouver Group). For further details see the ICMJE website http://www.icmje.org/.
Regular papers
Regular papers are the main form of publication of new research results in FEBS Journal. There is no formal limitation on length but a regular paper rarely exceeds about 7500 words (39 000 characters, without spaces). Shorter papers are of course welcome and the Editors will make recommendations for shortening any paper if that appears appropriate without loss of essential content. A concise well-written paper is easier for the Editor and referees to evaluate and this can help to speed up publication.
Reviews and minireviews
Authors wishing to submit a Review article or Minireview Series should contact the Reviews Editor, Prof. Ferdinand Hucho, email: hucho@chemie.fu-berlin.de.
A Minireview Series normally comprises three to five short review articles on related topics. Each minireview should be submitted as a separate manuscript by the corresponding author or coordinator of the series.
The coordinator is expected to provide a short overview of the series, which should be a maximum of 600 words and contain no references, figures or tables. In addition, we request a short biography (maximum 100 words) and also a photograph as a separate TIFF file (with a resolution of 300 dpi). The overview and biography should be uploaded together as a separate manuscript.
The coordinator should arrange for a general title for the Minireview Series and ensure that this recurs in the separate title of each of the individual constituent papers. This is to emphasize their connectedness and to ensure they are picked up together in literature searches.
An Exclusive Licence Form is needed for the overview and for each minireview.
Meeting Reports
A Meeting Report should begin with a proper introduction to the field, explain what the hot topics are, what the major advances appeared to be, and include some critical summing up of the field on the part of the author of the report. Thus it should resemble a review article, but be centred on a meeting. All topics in the general area of the molecular life sciences are welcome. Prospective authors should consult the Reviews Editor (Ferdinand Hucho: hucho@chemie.fu-berlin.de) or the Editor-in-Chief (Richard Perham: perham@camfebs.co.uk)
Papers with mathematical models
For papers that contain a mathematical model, FEBS Journal offers the opportunity for specialist refereeing of such articles plus online publication of live versions of the models for accepted manuscripts.
Authors are requested to submit an ASCII text file containing the model description (reaction stoichiometries, rate equations, parameter values and initial conditions, i.e. everything that is needed to program the model) in parallel to their manuscript file, following the instructions given at http://jjj.biochem.sun.ac.za/journals/febsj/submit.html. Models can also be submitted in SBML format. The files should be sent as an email attachment to Prof. Jacky Snoep (email: jls@sun.ac.za) after online submission of the manuscript at http://mc.manuscriptcentral.com/febsj. The manuscript number allocated to the manuscript should be quoted in the email containing the file of the associated model. The email containing the model should be copied to the Editorial Office (email: febsj@camfebs.co.uk) for information. At this stage the model will be converted to a replica that can be run over the Internet only by the reviewers of the paper. If the paper is accepted for publication in FEBS Journal, the model will subsequently be made freely accessible online.
The submission letter should clearly indicate that it is requested that the paper be treated technically as a modelling paper. When it is published in the Journal, the paper will not be distinguishable from its normal counterparts, except for a reference to the website that contains the model.
Accepted manuscripts can be provided as LaTex files but, as our production editing procedures use a Word-based system, the use of LaTeX files may result in slight delays at proof stage. Manuscripts supplied in LaTex format should be accompanied by a pdf version, for reference.
Papers with three-dimensional models of proteins
If your manuscript describes a three-dimensional model of a protein that has been manually built, you should consider depositing it in the PMDB database (http://www.caspur.it/PMDB see also NAR 34, 306-309). The database will return a unique identifier which you can include in your manuscript, thereby allowing readers to have access to your model without the need to contact you directly. The accession number should be included in the manuscript e.g. as a footnote on the first page: 'Database: model data are available in the PMDB database under the accession number XXXX'. The model can be stored in the database as either a full model with 3D coordinates in PDB format, or as an alignment to a known structure in the CASP format. You may keep your model on hold (i.e. not public) for up to three months after deposition.
Sequence data
Sequences should be treated as follows:
NB All accession numbers must be obtained before the paper can be accepted for publication
Results for proteins and nucleic acids from X-ray diffraction and NMR spectroscopy
Results from X-ray-diffraction and NMR studies should be treated as follows:
Ethical standards
Authors should consider and follow the ethical standards described below. The processing of papers may be delayed if there is any doubt about their conformity with these ethical standards.
1. Research Misconduct
Any breach of research or publication ethics including plagiarism, submission of fraudulent results/data including doctored figures, dual publication and false or incomplete attribution of authorship will not be tolerated. It will also be considered malpractice for an author to make inappropriate contact with a reviewer/editor during the review process with the aim of influencing the outcome. FEBS Journal will take action where misconduct is suspected, along the lines of the general principles outlined in Guidelines on Good Publication Practice produced by the Committee on Publication Ethics (COPE). The Guidelines are available from the web on: www.publicationethics.org.uk.
2. Animal Experiments
Where appropriate, authors should include in the Materials and methods (Experimental procedures) section :
3. Human Experiments
Research involving human subjects should comply with the Code of Ethics of the World Medical Association (Declaration of Helsinki), see http://www.cirp.org/library/ethics/helsinki/.
If human subjects are used,
The Editor reserves the right to reject a paper if there is doubt as to whether appropriate procedures have been used.
Please use standard fonts (Times, Times New Roman, Arial or Helvetica for general text; Courier or Courier New should be used for sequence alignments; Symbol font should be used to convert Greek characters and other non-standard characters such as the degree symbol) in your document. NB Asian-based font sets may produce uncertain results.
Authors must note that Word 2007 is not yet compatible with journal production systems. Unfortunately, the journal cannot accept Microsoft Word 2007 documents until such time as a stable production version is released. Please use Word’s ‘Save As’ option therefore to save your document as an older (.doc) file type.
Please note that Materials and methods or Experimental procedures should be located after the Discussion (not after Introduction).
Manuscripts must contain the following:
Title page
Title. This should be concise but informative. Subtitles, if necessary, should not follow a colon. Avoid abbreviations.
Authors' names. These should appear below the title, with the first or middle name of each author given in full. Given names should appear first.
Addresses. The laboratories where the work was carried out should be given below the authors' names. If the work was carried out at more than one laboratory, the names of the authors should be followed by superscript numbers, which should also precede the names of the appropriate laboratories.
Corresponding author(s). The full name and address of the author for correspondence, including fax and telephone numbers and email address should be given. The author should indicate if any of these should not be published. Authors are encouraged to provide the URL of their departmental Website for publication.
Running title. This should contain not more than 50 characters (including spaces).
Abbreviations. These should be defined unless included in the table of accepted abbreviations. They should be introduced only if essential because of frequent repetition or excessive length of the full name. For further details, see Nomenclature, symbols, units and abbreviations section below.
Enzymes. For enzymes it is recommended that Enzyme Commission (EC) numbers be supplied; these are provided in the NC-IUBMB list (www.chem.qmw.ac.uk/iubmb/enzyme/), which has a search facility and explains how to submit suggestions for new listings and for updating older entries.
Keywords. Up to five keywords for Regular papers and up to 10 for Reviews should be provided. These keywords will be printed alongside the summary.
Subdivision. For statistical purposes only, authors should assign their manuscript to one of the 28 fields given in Aims and Scope.
Manuscript
The manuscript should then contain the following sections in this order:
Introduction
Results
Discussion (It is permissible to combine Results and Discussion if a clearer, shorter paper is produced)
Materials and methods or Experimental procedures
Acknowledgements
References
Titles of Supplementary material
Tables
Schema
Figure legends
The reference list should appear in numerical order. Examples of the correct styles are shown below:
1. Tsubokawa M, Tohyama Y, Tohyama K, Asahi M, Inazu T, Nakamura H, Saito H & Yamamura H (1997) Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML193.Eur J Biochem249, 792-796.
2. Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
3. Langer T & Neupert W (1994) Chaperoning mitochondrial biogenesis. InThe Biology of Heat Shock Proteins and Molecular Chaperones (Morimoto RI, Tissičres A & Georgopoulos C, eds), pp. 53-83. Cold Spring Harbor Laboratory Press, Plainview, NY.
The use of a tool such as EndNote or Reference Manager is recommended for reference management and formatting. EndNote reference styles can be searched for at http://www.endnote.com/support/enstyles.asp, and Reference Manager reference styles can be searched for at http://www.refman.com/support/rmstyles.asp.
Images should not be modified to change their appearance or enhance any specific feature. Any adjustments of brightness and contrast or colour balance must be applied to the entire image and should not result in loss or gain of information. Unacceptable modifications include the addition, alteration or removal of a particular feature of an image. All figures in manuscripts will be examined for any indication of improper modifications. The final acceptance of all manuscripts is contingent on any concerns raised by referees being resolved.
Colour figures. The Journal encourages the publication of colour figures. Colour is free to authors where the Editors are of the view that it is essential. In all other instances, authors will be asked to return a signed copy of the completed Colourwork Agreement Form to the Editorial Office before their manuscript is passed to the Publisher. The Journal is pleased to allow authors to publish figures in colour free of charge in the online edition.
Reproduced figures
Cover illustrations
Authors with a colour figure appearing in an accepted paper that they believe would make a good image for the journal cover are invited to submit a copy of the figure 12 cm (width) by 14 cm (height), in colour, without any labels or scale bars. Please supply an electronic copy of the figure, with a short legend (max 15 words), following instructions in Preparation of electronic artwork for publication.
Preparation of electronic artwork for publication
Although low quality images are adequate for review purposes, print publication requires high quality images to prevent the final product being blurred or fuzzy. Information on the appropriate file formats for electronic graphics is available at http://www.blackwellpublishing.com/authors/digill.asp.
To facilitate production of publication quality artwork, we recommend that authors generate their artwork in software packages incorporating a SAVE AS or EXPORT TIFF/EPS function, e.g.: Adobe Illustrator 7.0 and above (EPS), Adobe Illustrator 9.0 (EPS but can also export files as TIFF), Deneba Canvas 6.0 and above (EPS), CorelDRAW 7.0 and above (EPS), Adobe Photoshop 4.0 and above (TIFF). You can EXPORT low resolution figs (GIF/JPG) from these packages for review purposes. EPS files can be produced from other applications [e.g. PowerPoint (see Electronic Artwork Guidelines)]BUT results can be unpredictable (e.g. fonts and shading not converted correctly, lines missing, dotted lines becoming solid). All scanned images embedded into other applications should be scanned at the recommended resolutions (see above).
Supplementary material
This is additional, peer-reviewed material that appears online but is not printed in the Journal. It must be submitted with the initial submission.
Nomenclature, abbreviations, units and symbols
FEBS Journal prefers abbreviations and nomenclature to follow internationally agreed recommendations, e.g. those of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (see www.chem.qmw.ac.uk/iubmb/nomenclature), however:
English language editing before submission
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at www.blackwellpublishing.com/bauthor/english_language.asp. All services are to be arranged and paid for by the author, and use of one of these services does not guarantee acceptance or preference for publication.
Exclusive licence form
Authors will be required to sign an Exclusive Licence Form (ELF) for all papers accepted for publication. Signature of the ELF is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. Only one signature is required; any author can sign, after agreement with the co-authors that he is signing on their behalf. Please note that signature of the ELF does not affect ownership of copyright in the material. (Government employees need to complete the Author Warranty sections, although copyright in such cases does not need to be assigned.) The ELF can be downloaded here or from Instructions and Forms at http://mc.manuscriptcentral.com/febsj/.
Online Open
OnlineOpen is a pay-to-publish service from Wiley-Blackwell that offers authors whose papers are accepted for publication the opportunity to pay up-front for their manuscript to become open access (i.e. free for all to view and download) via the Online Journal website. Each OnlineOpen article will be subject to a one-off fee to be met by or on behalf of the Author in advance of publication. Upon online publication, the article (both full-text and PDF versions) will be available to all for viewing and download free of charge. The print version of the article will also be branded as OnlineOpen and will draw attention to the fact that the paper can be downloaded for free via the Online Journal website.
The OnlineOpen fee is charged at a per page rate of £250/€375/$500 with a minimum charge of £1,500/€2,250/$3,000 (for papers with 6 pages or less) and a maximum charge of £5,000/€7,500/$10,000 (for papers with 20 pages or more).
Any authors wishing to publish their paper as an OnlineOpen article will be required to complete the combined payment and copyright licence form available from our website at:
www.blackwellpublishing.com/pdf/FEBS_OOF.pdf
(Please note this form is for use with OnlineOpen material ONLY.)
The form should be completed at proof stage, and once complete should be sent to the Production Editor at FEBSJournal@oxon.blackwellpublishing.com along with the corrected proof. Prior to acceptance there is no requirement to inform the Editorial Office that you intend to publish your paper OnlineOpen. On acceptance of the paper you should inform the Editorial Office if the paper is intended for OnlineOpen publication, and that the combined payment and copyright licence form will be returned at proof stage in place of an Exclusive Licence Form.
Embargo Period
After submission authors will retain the right to publish their paper in various media/circumstances: in particular authors are entitled at any time to post an electronic version of their submitted article online. Authors may post their accepted version (i.e as originally submitted for publication in FEBS Journal, and revised to take account of peer review comments) 12 months after the date of publication. Articles may be posted on personal websites, employer's website/repository and on free public servers in the subject area. Electronic versions of the accepted article must include a link to the published version online. Please note that authors are not permitted to post the Blackwell Publishing PDF version of the article online. Please see Exclusive Licence Form for further details.
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate
Permissions
Authors or a third party wishing to reproduce figures, tables or brief quotations from the text of articles published in FEBS Journal for non-commercial purposes may do so, providing the original publication is acknowledged accordingly and the approval of all the authors is obtained. No special permission is needed from either FEBS or the Publisher for this. If authors or a third party wish to use a major part of an article or an entire article elsewhere, whether in English or in any translation, permission must be asked from the Publisher, who will if necessary contact FEBS, the licence holder.
Publication date
Papers accepted for publication in FEBS Journal will be placed on the online version of the journal, as soon as they are ready for publication. This can occur at any time up to 3 weeks in advance of the cover date of the printed issue. Authors should take this into account when planning their intellectual and patent activities related to a document.
NEW: Online production tracking is now available for your article through Blackwell Author Services.
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don't need to contact the production editor to check on progress. Visit www.blackwellpublishing.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Author material archive policy
Please note that unless specifically requested, Blackwell Publishing will dispose of all submitted hardcopy or electronic material two issues after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible if you have not yet done so.